Physician profile
Hunter Lee
NPI 1821634791
$985.97
in general payments reported to CMS, 2019-2025
6 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $100 · 2022: $305 · 2023: $119 · 2024: $291 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455 · Travel and Lodging: $115 · Gift: $10.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.30 |
| Travel and Lodging | $114.83 |
| Gift | $10.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $317.83 | 2023-2025 | Invisalign, Invisalign First - Comprehensive, Invisalign System - Moderate |
| American Orthodontics Corporation | $236.27 | 2022-2023 | Empower-Metal, Lp and Ifit Tubes, Radiance |
| Solventum Corporation | $206.14 | 2024-2025 | Clarity Advanced, Apc Flash-Free Clarity Advanced, 3m Unitek Victory Series |
| 3m Company | $139.67 | 2021-2023 | Clarity Aligners, Transbond Plus |
| Zimmer Biomet Holdings, INC. | $83.34 | 2021 | |
| Ultradent Products INC | $2.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.